摘要
目的探讨老年ST段抬高型急性心肌梗死(STEMI)患者急诊经皮冠状动脉介入治疗(PCI)后无复流的独立预测因素。方法人选668例STEMI并急诊成功行PCI的老年患者,分为无复流组和复流组,收集患者的临床、冠状动脉造影和PCI资料评价无复流,分析评价无复流的独立预测因素。结果668例老年患者中,发生无复流181例(27.1%)。多元Logistic回归分析结果显示,入院收缩压〈100mmHg(1mmHg=0.133kPa)、侧支血流0~1级、PCI前血栓负荷评分≥4分和使用主动脉内气囊反搏是老年STEMI患者急诊PCI后无复流的独立预测因素。随着无复流独立因素数量增加,无复流发生率显著升高,分别具有0、1、2、3和4个独立预测因素时无复流发生率分别是10.0%(2/20)、13.7%(32/233)、30.8%(85/276)、38.1%(37/97)和59.5%(25/42),差异有统计学意义(χ2=25.796,P〈0.01)。结论老年STEMI患者急诊PCI后无复流的独立预测因素为人院收缩压〈100mmHg、侧支血流分级O~1级、PCI前血栓评分≥4分和使用主动脉内气囊反搏。
Objective To identify independent predictors of no-reflow after primary percutaneous coronary intervention (PPCI) in aged patients with ST-elevation acute myocardial infarction (STEMI), and thus construct a no-fellow predicting model. Methods Total of 668 aged patients with STEMI and successfully treated with PPCI were divided into the no-reflow group and the normal flow group. All clinical, angiographic and procedural data were collected. Multiple logistic regression analysis was used to identify independent no-reflow predictors. Results The no-reflow was found in 181 of 668 (27.1%) patients. Multiple stepwise logistic regression analysis identified that admission systolic blood pressure (SBP)〈100 mm Hg, collateral circulation 0-1 grade, pre-PCI thrombus score ≥ 4, and intra-aortic balloon pump (IABP) use before PCI were independent no- reflow predictors. The no-reflow incidence significantly enhanced as the numbers of independent predictors increased C10.0% (2/20), 13.7% (32/233), 30.8% (85/276), 38. 1% (37/97), and 59.5% (25/42) in patients with 0, 1, 2, 3, and 4 independent predictors, respectively,χ2=25. 796, P〈0.01) 3. Conclusions The no-reflow predictors are admission SBP %100 mm Hg, collateral circulation 0-1grade, pre-PCI thrombus score≥4, and IABP use before PCI in patients with STEMI and treated with PPCI. The prediction model may provide basis for therapeutic decision.
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2011年第9期705-709,共5页
Chinese Journal of Geriatrics
基金
北京市科委科技支撑项目(Z09050700620909)
关键词
心肌梗死
血管成形术
经腔
经皮冠状动脉
无复流现象
Myocardial infarction
Angioplasty, transluminal, percutaneous coronary
No-reflow phenomenon